Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Revenue (2016 - 2025)

Historic Revenue for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to $20.0 million.

  • Agios Pharmaceuticals' Revenue rose 8608.57% to $20.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $54.0 million, marking a year-over-year increase of 4803.0%. This contributed to the annual value of $54.0 million for FY2025, which is 4803.0% up from last year.
  • Agios Pharmaceuticals' Revenue amounted to $20.0 million in Q4 2025, which was up 8608.57% from $12.9 million recorded in Q3 2025.
  • Agios Pharmaceuticals' 5-year Revenue high stood at $20.0 million for Q4 2025, and its period low was $832000.0 during Q1 2022.
  • Over the past 4 years, Agios Pharmaceuticals' median Revenue value was $7.8 million (recorded in 2023), while the average stood at $8.2 million.
  • Its Revenue has fluctuated over the past 5 years, first soared by 57415.87% in 2023, then soared by 655.76% in 2025.
  • Over the past 4 years, Agios Pharmaceuticals' Revenue (Quarter) stood at $4.3 million in 2022, then skyrocketed by 64.8% to $7.1 million in 2023, then surged by 51.06% to $10.7 million in 2024, then soared by 86.09% to $20.0 million in 2025.
  • Its last three reported values are $20.0 million in Q4 2025, $12.9 million for Q3 2025, and $12.5 million during Q2 2025.